JACQUELYN COCCIA: Open Payments
NPI 1679282115 · BATAVIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 23 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $635 · 2025 $472
Food & beverage: $472
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| SCPHARMACEUTICALS INC. | 3 | $54 |
| Novo Nordisk Inc | 3 | $52 |
| Amgen Inc. | 2 | $38 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Edwards Lifesciences Corporation | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: LEQVIO, JARDIANCE, FUROSCIX, Wegovy, REPATHA, INSPIRE, VYNDAQEL, AMVUTTRA.
Industry payments across NY — which companies pay providers there.
